Results 51 to 60 of about 8,099 (196)

Stereotactic Body Radiotherapy and Conventional Radiotherapy Induce Cytoskeleton Extension and Enlargement of Cell Morphology in Non-Small Cell Lung Cancer

Dose-Response, 2021
Stereotactic body radiotherapy (SBRT) is now widely used in cancer therapy. However, the biological effects of SBRT compared with conventional radiotherapy (CRT) are not clear.
Xiao Wang, Yanwei Lu, Zhiquan Qin, Haiwei Guo, Wenjuan Chen, Ting Ding, Jianming Tang, Haibo Zhang   +7 more
doaj   +1 more source

Lung V5 and Planning Target Volume/Lung Volume Ratio as Independent Risk Factors for ≥Grade 2 Radiation Pneumonitis after Moderately Hypofractionated Radiotherapy: A Retrospective Study

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Lung V5 and the planning target volume/lung volume ratio were identified as independent dosimetric risk factors for clinically significant radiation pneumonitis following moderately hypofractionated radiotherapy for lung cancer. Maintaining V5 < 35% may help mitigate this risk in clinical practice.
YuanYou Yang, FengXia Luo, Chao Wang, Gang Ren   +3 more
wiley   +1 more source

Stereotactic Body Radiation Therapy (SBRT) for Treatment of Lung Cancer

, 2022
This project explains stereotactic body radiation therapy (SBRT) and its role in treating lung cancers. Different types of SBRT treatment, statistics, toxicity, success rates, and data from studies are discussed.
Frazier, Camryn
core  

Bridging hope: Retrospective analysis of stereotactic radiotherapy in patients with hepatocellular carcinoma-A promising and cost-effective solution for low-and middle-income countries

Cancer Research, Statistics, and Treatment
Background: Hepatocellular carcinoma (HCC) is one of the most common cancers among men in India. Stereotactic body radiation therapy (SBRT) has recently become a promising treatment modality for HCC before liver transplantation.
Rakesh Kapoor, Treshita Dey, Divya Khosla, Sunil Taneja, Naveen Kalra, Rajesh Gupta   +5 more
doaj   +1 more source

Normal tissue toxicity after small field hypofractionated stereotactic body radiation

Radiation Oncology, 2008
Stereotactic body radiation (SBRT) is an emerging tool in radiation oncology in which the targeting accuracy is improved via the detection and processing of a three-dimensional coordinate system that is aligned to the target.
Constine Louis S, Milano Michael T, Okunieff Paul   +2 more
doaj   +1 more source

Abscopal effect in metastatic breast cancer treated with stereotactic body radiotherapy in the absence of immunotherapy

Frontiers in Oncology, 2023
PurposeIn this study, we aimed to assess the abscopal effect (AE) after CyberKnife stereotactic body radiotherapy (SBRT) in metastatic breast cancer patients without immunotherapy.MethodsWe reviewed breast cancer patients who received SBRT with a ...
Jae Sik Kim, Ah Ram Chang
doaj   +1 more source

Oligoprogressive renal cell carcinoma: What is the role of surgery?

BJU International, EarlyView.
Objective To provide an overview of the biological mechanism and pattern of oligoprogression in renal cell carcinoma (RCC) and the most updated role of surgery in this setting, highlighting scientific gaps and informing future implications. Methods A non‐systematic search of PubMed/MEDLINE was performed in August 2025 including guidelines, reviews, and
Chiara Re, William H.J. Ince, Leo Bickley, James P. Blackmur, Mouhamad H. Ismail, Justicia Kyeremeh, Teele Kuusk, Eva Mendes Serrao, James O. Jones, Grant D. Stewart   +9 more
wiley   +1 more source

SBRT for bridging and downstaging HCC before transplant [PDF]

Background & Aims: Stereotactic body radiotherapy (SBRT) has emerged as a bridging/downstaging therapy for patients with hepatocellular carcinoma (HCC) awaiting liver transplantation (LT).
Jaeckel, Elmar, O'Kane, Grainne M., Lee, Cameron, Lukovic, Jelena, Hosni, Ali, Wong, Rebecca, Magyar, Christian T.J., Ghanekar, Anand, Dawson, Laura A., Grant, Robert C., Kim, Tae Kyoung, Selzner, Markus, Kim, John, Sapisochin, Gonzalo, McGilvray, Ian, Saha, Saheli, Shwaartz, Chaya, Cattral, Mark, Mesci, Aruz, Claasen, Marco P.A.W.; id_orcid, Selzner, Nazia, Li, Zhihao, Reichman, Trevor, Rajendran, Luckshi, Sayed, Blayne A., Naidoo, Catherine Soo Yee, Vogel, Arndt, Barry, Aisling, Yan, Michael   +28 more
core   +1 more source

Dose-escalated SBRT for borderline and locally advanced pancreatic cancer. Feasibility, safety and preliminary clinical results of a multicenter study

Clinical and Translational Radiation Oncology
Background: Pancreatic Stereotactic Body Radiotherapy (SBRT) allows for the administration of a higher biologically effective doses (BED), that would be essential to achieve durable tumor control.
B. Salas, L. Ferrera-Alayón, A. Espinosa-López, A. Vera-Rosas, E. Salcedo, A. Kannemann, A. Alayon, R. Chicas-Sett, M. LLoret, P.C. Lara   +9 more
doaj   +1 more source

Retrospective Analysis of Survival and Adverse Effects Associated With Stereotactic Body Radiation Therapy in 12 Dogs With Hepatocellular Carcinoma

Veterinary and Comparative Oncology, EarlyView.
ABSTRACT This retrospective analysis evaluated 12 dogs with hepatocellular carcinoma (HCC) who received stereotactic body radiation therapy (SBRT). Dogs received between 6 and 25 Grey (Gy) per fraction for 1–5 fractions for a total dose of 13–30 Gy. Eleven patients (92%) experienced acute adverse effects (AE), with the majority being VRTOG grade 2–3 ...
Victoria Lee Newberry, Mary‐Keara Boss, Del Leary, Tiffany W. Martin   +3 more
wiley   +1 more source